Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
24.37
-0.95 (-3.75%)
Oct 6, 2026, 4:00 PM EDT - Market closed
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.57 billion as of October 6, 2026. Its market cap has increased by 12.27% in one year.
Market Cap
1.57B
Enterprise Value
1.22B
1-Year Change
12.27%
Ranking
Category
Stock Price
$24.37
ChartMarket Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.57B, an increase of 95.47%. That is a compound annual growth rate of 9.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 1.57B | -13.26% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nuvation Bio | 1.77B |
| Novavax | 1.76B |
| Septerna | 1.74B |
| Generate Biomedicines | 1.74B |
| Intellia Therapeutics | 1.70B |
| Braveheart Bio | 1.68B |
| Syndax Pharmaceuticals | 1.60B |
| uniQure | 1.54B |